Ibrutinib + Venetoclax Promising for Chronic Lymphocytic Leukemia

WEDNESDAY, June 23, 2021 -- Combination therapy with ibrutinib and venetoclax seems beneficial for patients with previously untreated chronic lymphocytic leukemia (CLL), according to a study published online June 10 in JAMA Oncology. Nitin Jain,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news